TRICIA CALDWELL: Open Payments
NPI 1811431695 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,809 in 103 payments from 27 companies in 2025. Trend: 2023 $2,218 · 2024 $3,070 · 2025 $1,809
Food & beverage: $1,809
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $240 |
| Amgen Inc. | 21 | $174 |
| ABBVIE INC. | 9 | $153 |
| Collegium Pharmaceutical, Inc. | 11 | $147 |
| Phathom Pharmaceuticals, Inc. | 2 | $145 |
| GlaxoSmithKline, LLC. | 9 | $144 |
| Viatris Specialty LLC | 5 | $114 |
| Teva Pharmaceuticals USA, Inc. | 5 | $91 |
| Astellas Pharma US Inc | 4 | $83 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $63 |
Products named: AIRSUPRA, VOQUEZNA, OTEZLA, Belbuca, YUPELRI, TRELEGY ELLIPTA, AUSTEDO XR, Veozah.
Industry payments across AZ — which companies pay providers there.
